Repurposing existing agents as adjunct therapies for glioblastoma

Neuro-oncology Practice
Benjamin Purow

Abstract

Numerous non-oncologic medications have been found in the last decade to have anti-cancer properties. While the focus in oncology research should clearly remain on deriving new therapeutic strategies, repurposing these existing medications may offer the potential to rapidly enhance the effectiveness of treatment for resistant cancers. Glioblastoma, the most common and lethal brain cancer, is highly resistant to standard therapies and would benefit from even minor improvements in treatment. Numerous agents already in the clinic for non-cancer applications have been found to also possess potential against cancer or specifically against glioblastoma. These include agents with activities affecting oxidative stress, the immune reponse, epigenetic modifiers, cancer cell metabolism, and angiogenesis and invasiveness. This review serves as a guide for potential ways to repurpose individual drugs alongside standard glioblastoma therapies.

References

Nov 1, 1976·Postgraduate Medical Journal·G D SchottA M Hayler
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T S HuangJ K Lin
Jan 1, 1988·Medical and Pediatric Oncology·T R SpitzerR Weisman
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Oct 20, 1995·The Journal of Biological Chemistry·S Singh, B B Aggarwal
Aug 1, 1996·The Journal of Clinical Investigation·O V VolpertN P Bouck
Dec 1, 1996·American Journal of Clinical Oncology·M D PradosM Malec
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·J YrjänheikkiJ Koistinaho
May 4, 1999·European Journal of Pharmacology·E A KalkmanR G Schoemaker
Aug 3, 2000·Journal of the National Cancer Institute·C Vanchieri
Mar 6, 2003·Journal of the National Cancer Institute·Jaime R MerchanVikas P Sukhatme
Sep 2, 2003·Mutation Research·Kazuhiko OgawaShosuke Kawanishi
Jul 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evanthia GalanisUNKNOWN North Central Cancer Treatment Group
Jul 14, 2005·Investigational New Drugs·Susan M ChangUNKNOWN North American Brain Tumor Consortium and the National Cancer Institute
Jun 24, 2006·Chemistry & Biology·Min Gyu LeeRamin Shiekhattar
Oct 26, 2006·Cancer Research·Mahvash ZakikhaniMichael Pollak
Dec 23, 2006·Nature Reviews. Immunology·Hua YuDrew Pardoll
Jan 20, 2007·The Journal of Clinical Investigation·Ravi K AmaravadiCraig B Thompson
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J VredenburghHenry S Friedman
Mar 14, 2008·Nature·Heather R ChristofkLewis C Cantley
Jun 27, 2008·The New England Journal of Medicine·Benjamin S BrookeHarry C Dietz
Aug 19, 2008·Biochemical Pharmacology·L A HogarthS A Coulthard
Nov 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Huafeng ZhangGregg L Semenza
Feb 18, 2009·Cancer Immunology, Immunotherapy : CII·Claire BanissiAntoine F Carpentier
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evanthia GalanisJan C Buckner
May 22, 2009·Journal of Neurochemistry·W Joon Chung, Harald Sontheimer
Oct 31, 2009·Journal of Cellular and Molecular Medicine·R RattanV Shridhar
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven Grant
Nov 26, 2009·Cancer Research·Mario-Luca SuvàIvan Stamenkovic
Feb 4, 2010·Molecular and Cellular Biology·GuoQiang SunYanhong Shi

❮ Previous
Next ❯

Citations

Feb 10, 2020·Apoptosis : an International Journal on Programmed Cell Death·S I OmoruyiS Prince
Jun 20, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Ciaran Scott HillKristian Aquilina
Apr 28, 2019·Journal of Cancer Research and Clinical Oncology·Erlend SkagaEinar O Vik-Mo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.